Annotation Detail

Information
Associated Genes
PTGS2
Associated Variants
PTGS2 UNDEREXPRESSION
Source Database
MMMP
Description
In this phase II RCT (advanced melanoma), combination therapy was associated with significantly improved progression free survival. Note: rofecoxib has been withdrawn from the market due to cardiovascular toxicity
MMMP State
inhibited by, activated by
MMMP Molecule
COX-2, PPAR gamma
MMMP Modifier
Rofecoxib + Pioglitazone
MMMP Relationship
sensitivity to
MMMP Drug
Trofosfamide
MMMP Model
6
MMMP Reference
Reichle A, Melanoma Res 2007, 17:360-4
MMMP DNA/mRNA/Protein
protein
Drugs
Drug NameSensitivitySupported
TrofosfamideSensitivitytrue